*Metro North Kidney Health Service, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia

†Faculty of Medicine, University of Queensland, St Lucia, QLD, Australia

‡School of Medicine, Griffith University, Southport, QLD, Australia

§Metro South Integrated Nephrology and Transplant Services, Princess Alexandra Hospital, Woolloongabba, QLD, Australia

∥Australasian Kidney Trials Network (AKTN), University of Queensland, St Lucia, QLD, Australia

¶Centre for Health Services Research, University of Queensland, St Lucia, QLD, Australia

#Translational Research Institute, Brisbane, QLD, Australia

**Department of Anaesthesia, Princess Alexandra Hospital, Metro South Health Service, Woolloongabba, QLD, Australia

††Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia

‡‡Australia and New Zealand Dialysis and Transplant Registry (ANZDATA), South Australia Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia

§§Adelaide Medical School, The University of Adelaide, SA, Australia

∥∥Faculty of Medicine, University of Western Australia, Perth, WA, Australia

¶¶Sir Charles Gairdner Hospital, Nedlands, WA, Australia

##Department of Nephrology, Royal Hobart Hospital, Hobart, TAS, Australia

***School of Medicine, University of Tasmania, TAS, Australia

†††Renal Services, ACT Health, ACT, Australia

‡‡‡School of Medicine, Australian National University (ANU), ACT, Australia

§§§Metro North Health Service, Herston, QLD, Australia

Supported by the Royal Australasian College of Physicians (D.P. is the recipient of the Royal Australasian College of Physicians Jacquot Research Entry Scholarship 2019–2020), Metro South Health Research Support Scheme Small Project Grant 2018, and University of Queensland Infrastructure Grant 2017.

D.W.J. is a current recipient of an Australian National Health and Medical Research Council Leadership Investigator Grant. D.W.J. has received consultancy fees, research grants, speaker’s honoraria and travel sponsorships from Baxter Healthcare and Fresenius Medical Care, consultancy fees from Astra Zeneca, Bayer, and AWAK, speaker’s honoraria from ONO and BI & Lilly, and travel sponsorships from Ono and Amgen. C.M.H. has received funding from Janssen and GlaxoSmithKline to her institution for trial steering committee roles and research grant support to her institution from Shire, Baxter, Fresenius, and Otsuka and travel sponsorship from Otsuka. N.B. has received honoraria from Baxter; Education and travel grants from Roche and Amgen, and Consultancy fees from Astra Zeneca and Vifor. The remaining authors report no conflicts of interest.

[email protected], [email protected]

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.annalsofsurgery.com.